Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. (Record no. 28642045)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02314 a2200697 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517230157.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201905s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2213-2619 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S2213-2600(18)30264-9 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wang, Zhijie |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190531 |
| 245 00 - TITLE STATEMENT | |
| Title | Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Respiratory medicine |
| Date of publication, distribution, etc. | 09 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 681-690 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adenocarcinoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers, Tumor |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Circulating Tumor DNA |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | DNA Mutational Analysis |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gefitinib |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genes, Tumor Suppressor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genes, erbB-1 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Intention to Treat Analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sensitivity and Specificity |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cheng, Ying |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | An, Tongtong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gao, Hongjun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Kai |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhou, Qing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hu, Yanping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Song, Yong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ding, Cuimin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peng, Feng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liang, Li |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hu, Yi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huang, Cheng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhou, Caicun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shi, Yuankai |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Li |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ye, Xin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Meizhuo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chuai, Shaokun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhu, Guanshan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hu, Jin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wu, Yi-Long |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Jie |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Respiratory medicine |
| Related parts | vol. 6 |
| -- | no. 9 |
| -- | p. 681-690 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S2213-2600(18)30264-9">https://doi.org/10.1016/S2213-2600(18)30264-9</a> |
| Public note | Available from publisher's website |
No items available.